Crossmark

A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease

Crossref DOI link: https://doi.org/10.1007/s12325-021-01680-3

Published Online: 2021-03-12

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmidl, Doreen

Szalai, László

Kiss, Orsolya G.

Schmetterer, Leopold

Garhöfer, Gerhard
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03821415 at ClinicalTrials.gov

Documents that mention this clinical trial

A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease
https://doi.org/10.1007/s12325-021-01680-3
License Information

Text and Data Mining valid from 2021-03-12

Version of Record valid from 2021-03-12
More Information

Article History

Received: 8 January 2021

Accepted: 19 February 2021

First Online: 12 March 2021

Document is current

Any future updates will be listed below